ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
MIRXES-B
30.000
+6.700
28.76%
手動刷新
成交量:
917.87萬
成交額:
2.75億
市值:
82.90億
市盈率:
- -
高:
31.950
開:
29.000
低:
29.000
收:
23.300
資料載入中...
總覽
公司
新聞
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
醫健IPO解碼丨覓瑞登陸港交所,“滴血驗癌”故事能否持續撐起82億港元市值?
21世纪经济报道
·
05-23
覓瑞MIRXES-B於港交所主板成功上市,畢馬威作為其申報會計師提供專業服務
毕马威KPMG
·
05-23
港股綜述|恆瑞醫藥首日飆漲25%,Mirxes漲28%;阿里影業漲超8%,港股三大股指衝高回落
老虎资讯综合
·
05-23
MIRXES-B(02629)首掛收報30港元 較招股價高28.76%
金吾财讯
·
05-23
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02629"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02629","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":30,"timestamp":1747987708030,"preClose":23.3,"halted":0,"volume":9178741,"delay":0,"floatShares":276342331,"shares":276342331,"eps":0,"marketStatus":"休市中","change":6.7,"latestTime":"05-23 16:08:28","open":29,"high":31.95,"low":29,"amount":274942915,"amplitude":0.126609,"askPrice":30.05,"askSize":300,"bidPrice":30,"bidSize":9400,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1748223000000},"marketStatusCode":7,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":23.3,"openAndCloseTimeList":[[1747963800000,1747972800000],[1747976400000,1747987200000]],"volumeRatio":0,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","floatShares":276342331,"roa":"-51.53%","roe":"--","lyrEps":0,"shares":276342331,"dividePrice":0,"high":31.95,"amplitude":0.126609,"preClose":23.3,"low":29,"week52Low":29,"pbRate":"-5.07","psRate":"52.18","week52High":31.95,"institutionHeld":0,"latestPrice":30,"committee":0.938144,"eps":0,"divideRate":0,"volume":9178741,"delay":0,"ttmEps":0,"open":29,"prevYearClose":23.3,"prevWeekClose":23.3,"prevMonthClose":23.3,"prevQuarterClose":23.3,"fiveDayClose":23.3,"twentyDayClose":23.3,"sixtyDayClose":23.3},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02629\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02629\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537139092","title":"醫健IPO解碼丨覓瑞登陸港交所,“滴血驗癌”故事能否持續撐起82億港元市值?","url":"https://stock-news.laohu8.com/highlight/detail?id=2537139092","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537139092?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 20:12","pubTimestamp":1748002320,"startTime":"0","endTime":"0","summary":"截至23日收盘,这家miRNA明星公司每股报30.00港元,较发行价23.30港元大涨28.76%,总市值约82.90亿港元。觅瑞本次IPO全球发售4662万股,占发行完成后总股份的16.87%,每股定价23.30港元,募集资金总额约10.86亿港元,所得款净额约8.81亿港元。值得注意的是,觅瑞本次招股公开发售部分获25.51倍认购,国际发售部分获0.98倍认购。根据弗若斯特沙利文的资料,觅瑞是首家在基于血液的miRNA诊断检测领域及胃癌分子诊断检测领域获得FDA突破性医疗器械称号的公司。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-05-23/doc-inexqhfw5894956.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-05-23/doc-inexqhfw5894956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02629"],"gpt_icon":1},{"id":"2537380611","title":"覓瑞MIRXES-B於港交所主板成功上市,畢馬威作為其申報會計師提供專業服務","url":"https://stock-news.laohu8.com/highlight/detail?id=2537380611","media":"毕马威KPMG","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537380611?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 18:34","pubTimestamp":1747996440,"startTime":"0","endTime":"0","summary":"Mirxes Holding Company Limited于2025年5月23日在香港联合交易所主板完成首次公开发行并上市。毕马威作为觅瑞MIRXES-B上市的申报会计师参与该上市项目,提供专业服务。关于觅瑞MIRXES-B觅瑞MIRXES-B是一家总部位于新加坡的微小核糖核酸技术公司,致力于在亚洲关键市场提供疾病筛查诊断解决方案,提供用于癌症及其他疾病早期检测的基于血液的miRNA检测试剂盒。毕马威国际及其关联实体不提供任何客户服务。毕马威的名称和标识均属于毕马威国际的商标或注册商标。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2025-05-23/doc-inexpzxx0698661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02629"],"gpt_icon":0},{"id":"1100549993","title":"港股綜述|恆瑞醫藥首日飆漲25%,Mirxes漲28%;阿里影業漲超8%,港股三大股指衝高回落","url":"https://stock-news.laohu8.com/highlight/detail?id=1100549993","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100549993?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 16:42","pubTimestamp":1747989772,"startTime":"0","endTime":"0","summary":"个股方面:“A+H药企龙头”恒瑞医药、“新加坡微小核糖核酸技术公司”Mirxes两只新股今日登陆港交所,分别收涨25.2%、28.76%。$中国卫生集团$今日复牌一度飙升超1.7倍,最终收涨110.71%,公司折让28.6%配股引入新投资者。阿里影业涨超8%,公司拟更名为大麦娱乐,$花旗$称IP商品潜力尚未完全释放。A股行情A股市场冲高回落,三大指数午后集体跳水。截至收盘,沪指跌0.94%报3348点,深证成指跌0.85%,创业板指跌1.18%。","market":"us","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSI","02629","01276","01060"],"gpt_icon":1},{"id":"2537618511","title":"MIRXES-B(02629)首掛收報30港元 較招股價高28.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537618511","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537618511?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 16:38","pubTimestamp":1747989480,"startTime":"0","endTime":"0","summary":"金吾财讯 | MIRXES-B(02629)首挂收报30港元,较招股价高28.76%,全日成交917.87万股,成交额2.75亿港元。不计手续费,每手100股,账面赚670港元。首挂开报29港元,亦为全日最低价,较招股价高24.46%,全日最高31.95港元。最新总市值82.9亿港元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/NDRlODdhNTE5YzIwYjYxODZjOWYzMjY3ODIxMDI2ODM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDRlODdhNTE5YzIwYjYxODZjOWYzMjY3ODIxMDI2ODM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0}],"pageSize":4,"totalPage":15,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02629\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02629\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02629\",market:\"HK\",delay:false,,,undefined,":{}}}